MIRA Pharmaceuticals, Inc.
NASDAQ: MIRA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Erez Aminov
- Employees
- 2
- Headquarters
- Baltimore, United States
- IPO year
- 2023
- Market cap
- $38.3M
- Website
- https://mirapharmaceuticals.com
Loading MIRA…
Loading profile data…Frequently asked questions about MIRA
What does MIRA Pharmaceuticals, Inc. (MIRA) do?
MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog. This compound is undergoing investigation for its potential to address anxiety and the cognitive impairments fr...
Where does MIRA trade?
MIRA Pharmaceuticals, Inc. (MIRA) trades on the NASDAQ Capital Market.
What sector is MIRA in?
MIRA Pharmaceuticals, Inc. (MIRA) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of MIRA Pharmaceuticals, Inc.?
Erez Aminov is the chief executive officer of MIRA Pharmaceuticals, Inc. (MIRA).
Where is MIRA Pharmaceuticals, Inc. headquartered?
MIRA Pharmaceuticals, Inc. is headquartered in United States.
Does MIRA pay a dividend?
MIRA Pharmaceuticals, Inc. (MIRA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MIRA go public?
MIRA Pharmaceuticals, Inc. (MIRA) completed its initial public offering in 2023.